BioLineRx Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BLRX | SNGX | BIVI | SBTX.L | BDRX | ATORX.ST | |
|---|---|---|---|---|---|---|
| Market cap | 9.26M | 7.64M | 11.63M | 12.05M | 1.41M | 38.54M |
| P/E (TTM) | — | — | — | — | 0.0 | — |
| Forward P/E | -0.7 | -1.4 | -2.4 | 24.6 | — | -0.1 |
| Price/book | 0.6 | 1.1 | 1.0 | 1.5 | 0.0 | 0.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −45.11% | −73.91% | −10.67% | −70.00% | −98.73% | −99.44% |
| Today | −2.62% | −1.49% | −22.54% | −11.43% | −4.61% | +0.93% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BLRX news ›Reviewing BioLineRx (NASDAQ:BLRX) and Vertex Pharmaceuticals (NASDAQ:VRTX)
Posted by Danessa Lincoln on Oct 30th, 2026 BioLineRx (NASDAQ:BLRX – Get Free Report) and Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two…
HAX1 review highlights context-dependent roles in cancer progression
A 2026 review finds that the molecular scaffold HAX1 supports tumor growth, invasion, hypoxic adaptation and treatment resistance while showing promise as a prognostic biomarker and selective therapeutic target. Article Title: HAX1 in…
Transcript : BioLineRx Ltd., Q1 2026 Earnings Call, May 27, 2026
Presentation Operator MessageOperator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2026 Financial Results Conference. [Operator Instructions] I would now... Transcript : BioLineRx Ltd., Q1 2026…
BioLineRx Ltd. And Hemispherian AS Highlight New Data On GLIX1 At The American Society Of Clinical Oncology Annual Meeting
BioLineRx Ltd. and Hemispherian AS announced that two abstracts featuring GLIX1 will be published at the American Society of Clinical Oncology 2026 Annual Meeting, which is being held May 29-June 2,...
BioLineRx Ltd.: Relative Strength Chart - Stock TEL AVIV STOCK EXCHANGE
Compare BioLineRx Ltd. with the company of your choice via a Relative Strength chart. Real-time BLRX price, TEL AVIV STOCK EXCHANGE stock exchange Relative Strength Chart BioLineRx Ltd. Biotechnology & Medical Research All financial news…
BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education Day
08 Oct, 2026, 14:00 IDT The presentations will highlight preclinical research evaluating GLIX1 across multiple glioblastoma models, as well as the design of the ongoing Phase 1/2a clinical trial evaluating GLIX1 in patients with recurrent…
BioLineRx Ltd.: Total Return chart (Dividends reinvested) - TEL AVIV STOCK EXCHANGE stock market
See the history of BioLineRx Ltd., with dividends reinvested. (Total Return chart) BLRX Stock market Total Return chart BioLineRx Ltd. Biotechnology & Medical Research All financial news and data tailored to specific country editions
BioLineRx Ltd. And Hemispherian AS Announce New GLIX1 Data Demonstrating Potent Anti-Tumor Effect In Glioblastoma
BioLineRx Ltd. and Hemispherian AS announced highly encouraging new preclinical data that further support the recently initiated Phase 1/2a clinical trial evaluating GLIX1 for the treatment of... and Hemispherian AS announced highly…
BioLineRx And Hemispherian AS Present GLIX1 Preclinical Efficacy Data And Phase 1/2a Trial Design
BioLineRx Ltd. and Hemispherian AS announced that two abstracts featuring GLIX1 have been accepted for presentation, including one selected for oral presentation highlighting the preclinical efficacy... and Hemispherian AS announced that…
BioLineRx Ltd. And Hemispherian AS Announces First Patient Dosed In Phase 1/2a Study Of GLIX1 For The Treatment Of Glioblastoma
BioLineRx Ltd. and Hemispherian AS announced that the first patient has been dosed in the first-in-human, Phase 1/2a study of GLIX1 for the treatment of recurrent and progressive glioblastoma and... and Hemispherian AS announced that the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com5
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.